Oracle Corporation $ORCL Stock: Quadrant Capital Group LLC Decreases Position

Quadrant Capital Group LLC cut its position in Oracle Corporation (NYSE:ORCL) by 12.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 64,841 shares of the enterprise software provider’s stock after selling 9,569 shares during the period. Quadrant Capital Group LLC’s holdings in Oracle were worth $9,285,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. Bank of New York Mellon Corp acquired a new stake in Oracle during the 2nd quarter worth $1,911,930,000. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in shares of Oracle in the second quarter valued at about $625,454,000. Corient Private Wealth LP acquired a new stake in shares of Oracle in the second quarter valued at about $186,175,000. First Trust Advisors LP lifted its stake in shares of Oracle by 23.3% in the first quarter. First Trust Advisors LP now owns 3,633,070 shares of the enterprise software provider’s stock worth $534,461,000 after buying an additional 685,570 shares in the last quarter. Finally, Public Employees Retirement System of Ohio purchased a new position in shares of Oracle in the second quarter worth about $94,955,000. 42.44% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, EVP Maria Smith sold 2,631 shares of the stock in a transaction that occurred on Tuesday, September 22nd. The shares were sold at an average price of $151.70, for a total value of $399,122.70. Following the completion of the sale, the executive vice president owned 64,357 shares of the company’s stock, valued at $9,762,956.90. This represents a 3.93% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Michael D. Sicilia sold 22,562 shares of the firm’s stock in a transaction that occurred on Tuesday, September 22nd. The stock was sold at an average price of $151.59, for a total transaction of $3,420,173.58. Following the sale, the chief executive officer owned 182,929 shares of the company’s stock, valued at $27,730,207.11. This represents a 10.98% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 36,075 shares of company stock valued at $5,342,123 over the last ninety days. Company insiders own 38.40% of the company’s stock.

Analysts Set New Price Targets

A number of research firms recently weighed in on ORCL. Sanford C. Bernstein restated a “buy” rating on shares of Oracle in a research report on Friday, September 25th. Royal Bank Of Canada dropped their price objective on shares of Oracle from $190.00 to $165.00 and set a “sector perform” rating for the company in a research note on Friday, September 11th. Citigroup reiterated a “market outperform” rating on shares of Oracle in a report on Friday, October 2nd. Cantor Fitzgerald reissued an “overweight” rating and issued a $284.00 target price (up from $229.00) on shares of Oracle in a research note on Friday, September 11th. Finally, Yorkville Ives assumed coverage on shares of Oracle in a research note on Wednesday, October 7th. They issued an “in-line” rating and a $155.00 target price on the stock. One analyst has rated the stock with a Strong Buy rating, thirty-five have issued a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $249.52.

More Oracle News

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: Oracle announced a collaboration with AstraZeneca to use its cloud, AI, analytics and real-world health data to improve clinical-trial recruitment, accelerate evidence generation and connect research with patient care. The agreement broadens Oracle’s AI opportunity beyond data centers and healthcare applications could create additional long-term growth. Oracle and AstraZeneca Partner to Advance AI-enabled Healthcare Innovation
• Positive Sentiment: A BNP Paribas software-reseller survey reportedly showed an “impressive inflection” in Oracle demand, supporting the view that cloud, database and AI sales momentum is improving. Oracle’s multicloud database revenue also grew sharply, allowing customers to use Oracle databases alongside applications hosted on rival clouds. Oracle Sees Stronger AI Demand as BNP Paribas Survey Shows Major Improvement
• Positive Sentiment: TD Cowen suggested Nvidia may help finance Oracle’s AI data-center buildout, potentially reducing Oracle’s need to fund the expensive infrastructure directly. Bank of America also maintained a bullish outlook and cited substantial upside potential. Nvidia May Be Helping Finance Oracle’s AI Data Centers
• Neutral Sentiment: Oracle’s Project Jupiter data-center campus is reportedly progressing quickly, but the company’s efforts to use alternative financing and its reported force-majeure position highlight the execution and funding challenges of its massive AI expansion. Oracle Calls Force Majeure Already?
• Negative Sentiment: Credit concerns remain a major risk. Investors are questioning whether Oracle can fund its large AI buildout without putting pressure on its balance sheet, while rising borrowing costs have increased downgrade concerns for Oracle bonds. Analysts also warn that the stock may still be overvalued despite its recent decline. Oracle Bonds Face Downgrade Risks as AI Trade Fizzles

Oracle Stock Up 0.9%

Shares of ORCL opened at $130.77 on Wednesday. Oracle Corporation has a 52-week low of $114.50 and a 52-week high of $287.19. The company has a market capitalization of $395.42 billion, a PE ratio of 20.50, a price-to-earnings-growth ratio of 0.91 and a beta of 1.78. The stock has a fifty day simple moving average of $144.66 and a two-hundred day simple moving average of $158.56. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 1.89.

Oracle (NYSE:ORCL) last posted its quarterly earnings results on Thursday, September 10th. The enterprise software provider reported $1.92 EPS for the quarter, topping the consensus estimate of $1.74 by $0.18. The business had revenue of $19.34 billion for the quarter, compared to analyst estimates of $19.13 billion. Oracle had a return on equity of 48.85% and a net margin of 26.36%. The company’s quarterly revenue was up 29.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.47 EPS. Oracle has set its Q2 2027 guidance at 1.850-1.930 EPS and its FY 2027 guidance at 8.100-8.100 EPS. As a group, equities analysts forecast that Oracle Corporation will post 6.73 EPS for the current year.

Oracle Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 23rd. Shareholders of record on Friday, October 9th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, October 9th. This represents a $2.00 dividend on an annualized basis and a yield of 1.5%. Oracle’s payout ratio is 31.35%.

About Oracle

Oracle Corporation (NYSE: ORCL) is a global technology company that develops enterprise software, cloud infrastructure and database technologies. Its products help organizations store, manage, analyze and secure data, while supporting business operations across industries and geographies.

The company’s offerings include Oracle Database, Java, Oracle Cloud Infrastructure and a broad portfolio of cloud-based applications. These applications serve functions such as enterprise resource planning, financial management, human resources, supply-chain management, customer experience and industry-specific operations.